SEC Form 4 · accession 0001144204-15-021754
Amarantus Bioscience Holdings, Inc. · AMBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald Commissiong
Officer — CEO · Director
Period of report
Apr 8, 2015
Accepted (ET)
Apr 8, 2015 · 2:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001424812
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 8, 2015 | P | 37,000 | $0.0479 | A | 8,056,565 | D | |
| Common Stock | Apr 8, 2015 | P | 203,000 | $0.048 | A | 8,259,565 | D |
Table II — derivative securities
No Table II lines on this filing.